ORIC
OricFNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
Current thesis
Composite grade F from latest DB weights. Momentum 6.2 / Value 41.1
Posture
Defensive
Lead driver
Value
What changed
1 setup hits (3d) with net bullish as of 2026-06-02.
What can break
Mixed signals. Wait for cleaner trend confirmation.
Momentum
6
Value
41
Sentiment
N/A
Setup hits (3d)
1 · Net Bullish
AI TargetsBase - · Bull - · Bear -
Data freshness
Prices
As of 2026-06-02
Fundamentals
As of 2026-06-01 • Vendor: Data Vendor v1
Scores
As of 2026-06-02 • Model: HYBRID_IC_RP
AI Memo
Unavailable: No memo yet
Investment thesisAs of 2026-06-02
Investment thesis
As of 2026-06-02
Supporting evidence
What
Grade F · Defensive
Confidence Medium · Net Bullish
Target $21.23
Why
Momentum6 · Δ7d +0.8
Value41 · Δ7d +0.1
SentimentN/A · Δ7d -
So what
Weak posture (Net Bullish). Prioritize risk control and patience.
Lead driver: Value · See fundamentals
Momentum
6
52% active weight
Current posture
7d trendFlat
Δ7d
+0.8
Δ21d
+2.2
Value
41
48% active weight
Current posture
7d trendFlat
Δ7d
+0.1
Δ21d
+0.2
Sentiment
N/A
Coverage pending
No current score
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade F. Momentum 6.2 / Value 41.1
Fundamentals (TTM)As of 2026-06-01
Fundamentals (TTM)
As of 2026-06-01
Market Cap
$929.59M
Beta
1.34
Shares Out
97.39M
P/E (TTM) · Derived
-6.5
P/S (TTM)
-
P/FCF (TTM) · Derived
-6.49
Rev YoY
-
EPS YoY
+32.8%
Gross Margin
-
Op Margin
-
Net Debt
-$255.96M
Current Ratio
14.65
As of 2026-06-02 • Updated nightlySource: Internal modelMethodology